Zuprevo 180 mg/ml - Solution for injection
Zuprevo 180 mg/ml - Solution for injection
Authorised
- Tildipirosin
Product identification
Medicine name:
Zuprevo 180 mg/ml - Solution for injection
Active substance:
- Tildipirosin
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Tildipirosin180.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal47day47 days (Not authorised for use in lactating animals producing milk for human consumption.Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition)
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA96
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Vial (glass), Package_size:1 vial, Content:250 ml
- Packaging:Vial (glass), Package_size:1 vial, Content:100 ml
- Packaging:Vial (glass), Package_size:1 vial, Content:50 ml
- Packaging:Vial (glass), Package_size:1 vial, Content:20 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 29/02/2024
Bulgarian (PDF)
Published on: 29/02/2024
Croatian (PDF)
Published on: 29/02/2024
Czech (PDF)
Published on: 29/02/2024
Danish (PDF)
Published on: 29/02/2024
Dutch (PDF)
Published on: 29/02/2024
Estonian (PDF)
Published on: 29/02/2024
Finnish (PDF)
Published on: 29/02/2024
French (PDF)
Published on: 29/02/2024
German (PDF)
Published on: 29/02/2024
Greek (PDF)
Published on: 29/02/2024
Hungarian (PDF)
Published on: 29/02/2024
Icelandic (PDF)
Published on: 29/02/2024
Italian (PDF)
Published on: 29/02/2024
Latvian (PDF)
Published on: 29/02/2024
Lithuanian (PDF)
Published on: 29/02/2024
Maltese (PDF)
Published on: 29/02/2024
Norwegian (PDF)
Published on: 29/02/2024
Polish (PDF)
Published on: 29/02/2024
Portuguese (PDF)
Published on: 29/02/2024
Romanian (PDF)
Published on: 29/02/2024
Slovak (PDF)
Published on: 29/02/2024
Slovenian (PDF)
Published on: 29/02/2024
Spanish (PDF)
Published on: 29/02/2024
Swedish (PDF)
Published on: 29/02/2024
How useful was this page?:
